# Evaluation of Patient Satisfaction During Treatment With Dupilumab in Severe and Recurrent Nasosinusal Polyposis Despite Appropriate Medical and Surgical Treatment.

> **NCT06017427** · — · TERMINATED · sponsor: **IHU Strasbourg** · enrollment: 32 (actual)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT06017427
- **Lead sponsor:** IHU Strasbourg
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-08-30
- **Primary completion:** 2023-09-21
- **Final completion:** 2023-09-21
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** Number of inclusions sufficient for answering the main objective
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06017427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06017427, "Evaluation of Patient Satisfaction During Treatment With Dupilumab in Severe and Recurrent Nasosinusal Polyposis Despite Appropriate Medical and Surgical Treatment.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06017427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*